Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of leukemias and chronic myeloproliferative diseases with antibodies to EphA3

Treatment of leukemias and chronic myeloproliferative diseases with antibodies to EphA3

US Patent 8834870 · Granted Sep 16, 2014

Estimated economic value: $812,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-Siglec-7 antibodies having reduced effector function2024
Anti-Siglec-7 antibodies for the treatment of cancer2023
Methods and compositions for treating perennial allergic conjunctivitis and kera2021
Immunoglobulin variable region cassette exchange2021
Immunoglobulin variable region cassette exchange2021
Methods and compositions for treating fibrotic diseases2020
Methods and compositions for treating systemic mastocytosis2020
Methods and compositions for treating Siglec-8 associated diseases2019
Influenza vaccine and therapy2018
Anti-Siglec-8 antibodies and methods of use thereof2017
Antibodies to EphA32016
Antibodies to EphA32016